BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
Mainz, Germany, December 02, 2020 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the…
Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174;…
Roche announces FDA approval of Gavreto (pralsetinib) for people with advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers
Basel, 2 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the…
Innate Pharma 2021 Financial Calendar
MARSEILLE, France, Dec. 02, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
Innate Pharma 2021 financial calendar
Marseille, Dec. 02, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN:…
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys® Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein…
Reata Pharmaceuticals, Inc. Announces Pricing of Class A Common Stock Offering
PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or…
Allena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
NEWTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage,…
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome…
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…